Our Mission

To accelerate patient access to gene and cell therapy with quality, speed, and agility

Plasmids

Viral Vectors

Cell Therapy

About

Read More

About

Services

View More

NEWS

View More

2023-04-12

Forecyte Bio, a CGT CDMO, Hosted a Grand Opening for Its Brand-New GMP Facility in Shanghai, Just Two Months After Its Sister Site in the United States

2023-01-20

Forecyte Bio's Grand Opening of the CGMP Facility in Maryland

Forecyte Bio, CGT CDMO leader, officially opened its cGMP production suites for plasmid DNA, viral vector and cell therapy productions.

2022-11-18

The first day of the CIIE signed a strategic cooperation agreement

On November 6, 2022, Forecyte Bio, a trusted one-stop CDMO provider in the field of cell& gene therapy (CGT), and Thermo Fisher Scientific, a global leader in enabling technical advancement, signed and entered into a strategic cooperation agreement on the first day of the China International Import Expo.

2022-11-18

Forecyte Bio was listed in the "Top 10 Most Growing Innovative CXO Companies" in China”

On November 10, The 24th Shanghai International Forum on Biotechnology & Pharmaceutical Industry (Bio-Forum 2022) series｜China Biotechnology and Pharmaceutical Innovation Forum and 2022 China Biopharmaceutical Technology Innovation Value List Award was held in Shanghai, initiated by Shanghai Biopharmaceutics Industry Association (SBIA). Forecyte Bio was listed in the "Top 10 Most Innovative and Growing CXO Companies" in China.

Contact

Forecyte Bio Limited

US:

7495 New Horizon Way, Suite 130-150, Frederick，MD 21703
Tel.: +1 215-589-3593

China:

177 Yiwei Road, Pilot free trade zone, Shanghai, China
Tel.：+86 21 80438700
E-mail：info@forecytebio.com

Copyright © 2021 forecytebio.com All rights reserved.
沪ICP备2021022864号-1 power by：300.cn